Efficacy and safety of PCSK9 inhibitors in real life Antón González-Guerrero; Eugenia Navarrete-Rouco; David Benaiges; Eva Giralt-Steinhauer; Lidia Marcos; Anna Oliveras; Lluis Recasens; Juan Pedro-Botet;

Icosapent ethyl: From the REDUCE-IT trial to clinical practice Juan Pedro-Botet;

Strategies to improve cardiovascular health and treatment of dyslipidemia in Spain. Expert Insights Project Juan Pedro-Botet; Román Freixa; Juan José Tamarit; José López-Miranda; Rosa Fernández-Olmo; Ovidio Muñiz-Grijalvo; Rafael Vázquez-García; Carlos Guijarro; Luis Rodríguez-Padial; José Luis Díaz-Díaz; Marisol Bravo-Amaro; José Luís Hernández; José Antonio Alarcón-Duque; José Alfredo Martin-Armas; Martín García-López; Juan Cosín-Sales;